IRIS Accounts Production v24.2.0.383 07487836 Board of Directors Board of Directors 1.1.23 31.12.23 31.12.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh074878362022-12-31074878362023-12-31074878362023-01-012023-12-31074878362021-12-31074878362022-01-012022-12-31074878362022-12-3107487836ns15:EnglandWales2023-01-012023-12-3107487836ns14:PoundSterling2023-01-012023-12-3107487836ns10:Director12023-01-012023-12-3107487836ns10:Director22023-01-012023-12-3107487836ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3107487836ns10:SmallEntities2023-01-012023-12-3107487836ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3107487836ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3107487836ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3107487836ns10:FullAccounts2023-01-012023-12-3107487836ns10:RegisteredOffice2023-01-012023-12-3107487836ns5:CurrentFinancialInstruments2023-12-3107487836ns5:CurrentFinancialInstruments2022-12-3107487836ns5:Non-currentFinancialInstruments2023-12-3107487836ns5:Non-currentFinancialInstruments2022-12-3107487836ns5:ShareCapital2023-12-3107487836ns5:ShareCapital2022-12-3107487836ns5:SharePremium2023-12-3107487836ns5:SharePremium2022-12-3107487836ns5:RetainedEarningsAccumulatedLosses2023-12-3107487836ns5:RetainedEarningsAccumulatedLosses2022-12-3107487836ns5:PlantMachinery2023-01-012023-12-3107487836ns5:FurnitureFittings2023-01-012023-12-3107487836ns5:ComputerEquipment2023-01-012023-12-3107487836ns5:PlantMachinery2022-12-3107487836ns5:FurnitureFittings2022-12-3107487836ns5:ComputerEquipment2022-12-3107487836ns5:PlantMachinery2023-12-3107487836ns5:FurnitureFittings2023-12-3107487836ns5:ComputerEquipment2023-12-3107487836ns5:PlantMachinery2022-12-3107487836ns5:FurnitureFittings2022-12-3107487836ns5:ComputerEquipment2022-12-3107487836ns5:LeasedAssetsHeldAsLesseens5:ComputerEquipment2022-12-3107487836ns5:LeasedAssetsHeldAsLesseens5:ComputerEquipment2023-01-012023-12-3107487836ns5:LeasedAssetsHeldAsLesseens5:ComputerEquipment2023-12-3107487836ns5:LeasedAssetsHeldAsLesseens5:ComputerEquipment2022-12-3107487836ns5:CostValuation2022-12-3107487836ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3107487836ns5:WithinOneYearns5:CurrentFinancialInstruments2022-12-3107487836ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2023-12-3107487836ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2022-12-31
REGISTERED NUMBER: 07487836 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st December 2023

for

Wimbledon Neurocare Limited

Wimbledon Neurocare Limited (Registered number: 07487836)






Contents of the Financial Statements
for the Year Ended 31st December 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Wimbledon Neurocare Limited

Company Information
for the Year Ended 31st December 2023







DIRECTORS: Dr A Y M J Al-Memar
Dr O J F Foster





REGISTERED OFFICE: Unit 1 College Fields
16 Prince George Road
London
SW19 2PT





REGISTERED NUMBER: 07487836 (England and Wales)





ACCOUNTANTS: Sampson Fielding Ltd
34 - 35 Clarges Street
Mayfair
London
W1J 7EJ

Wimbledon Neurocare Limited (Registered number: 07487836)

Balance Sheet
31st December 2023

31/12/23 31/12/22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 122,906 184,069
Investments 5 156,240 156,240
279,146 340,309

CURRENT ASSETS
Debtors 6 1,074,756 913,481
Cash at bank 108,885 85,438
1,183,641 998,919
CREDITORS
Amounts falling due within one year 7 260,660 226,834
NET CURRENT ASSETS 922,981 772,085
TOTAL ASSETS LESS CURRENT LIABILITIES 1,202,127 1,112,394

CREDITORS
Amounts falling due after more than one year 8 (2,452 ) (9,476 )

PROVISIONS FOR LIABILITIES (25,772 ) (30,382 )
NET ASSETS 1,173,903 1,072,536

CAPITAL AND RESERVES
Called up share capital 514,048 514,048
Share premium 240,240 240,240
Retained earnings 419,615 318,248
SHAREHOLDERS' FUNDS 1,173,903 1,072,536

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Wimbledon Neurocare Limited (Registered number: 07487836)

Balance Sheet - continued
31st December 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19th September 2024 and were signed on its behalf by:




Dr O J F Foster - Director



Dr A Y M J Al-Memar - Director


Wimbledon Neurocare Limited (Registered number: 07487836)

Notes to the Financial Statements
for the Year Ended 31st December 2023

1. STATUTORY INFORMATION

Wimbledon Neurocare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

The financial statements are prepared in Pound Sterling which is the functional currency of the company and rounded to nearest pound.

Turnover
Turnover comprises revenue recognised by the company in respect of a range of services for the management of neurological conditions, hearing related conditions and balance disorders which includes assessment, diagnosis and treatment during the year, exclusive of Value Added Tax and trade discounts.

Services provided to patients are recognised as turnover according to the date when the treatments are provided.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery - 20% on cost
Fixtures and fittings - 15% on cost
Computer equipment - 20% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Wimbledon Neurocare Limited (Registered number: 07487836)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2023

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Debtors and creditors
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

Investments
Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through the profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Going concern
These financial statements have been prepared on the going concern basis, which presumes that the company is able to continue in operational existence for the foreseeable future. The company is reliant upon the continued support of its directors and creditors. If this support was withdrawn, the company would be unable to continue in operational existence. Adjustments would then have to be made to reduce the balance sheet values of assets to their recoverable amounts and to provide for any further liabilities that may arise. The company is unable to quantify the effect of such adjustments on the financial statements.

The directors believe that it is appropriate for the financial statements to be prepared on the going concern
basis.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2022 - 7 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1st January 2023 852,552 93,765 106,016 1,052,333
Additions - 786 - 786
At 31st December 2023 852,552 94,551 106,016 1,053,119
DEPRECIATION
At 1st January 2023 694,942 79,367 93,955 868,264
Charge for year 49,729 4,621 7,599 61,949
At 31st December 2023 744,671 83,988 101,554 930,213
NET BOOK VALUE
At 31st December 2023 107,881 10,563 4,462 122,906
At 31st December 2022 157,610 14,398 12,061 184,069

Wimbledon Neurocare Limited (Registered number: 07487836)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2023

4. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts or finance leases are as follows:
Computer
equipment
£   
COST
At 1st January 2023
and 31st December 2023 31,599
DEPRECIATION
At 1st January 2023 15,799
Charge for year 7,599
At 31st December 2023 23,398
NET BOOK VALUE
At 31st December 2023 8,201
At 31st December 2022 15,800

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1st January 2023
and 31st December 2023 156,240
NET BOOK VALUE
At 31st December 2023 156,240
At 31st December 2022 156,240

6. DEBTORS
31/12/23 31/12/22
£    £   
Amounts falling due within one year:
Trade debtors 199,839 171,860
Other debtors 868,717 735,421
1,068,556 907,281

Amounts falling due after more than one year:
Other debtors 6,200 6,200

Aggregate amounts 1,074,756 913,481

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/12/23 31/12/22
£    £   
Trade creditors 127,826 129,657
Taxation and social security 78,545 51,094
Other creditors 54,289 46,083
260,660 226,834

Wimbledon Neurocare Limited (Registered number: 07487836)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2023

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31/12/23 31/12/22
£    £   
Other creditors 2,452 9,476

9. OTHER FINANCIAL COMMITMENTS

The company acted as a guarantor to a lease agreement signed by a joint venture company (Sterling Healthcare Group Ltd) on 1st October 2020. That lease agreement covered the period from 1 October 2020 to 7 June 2047, with a rent of £189,688 per annum.